Jenny Nip

News

• Jenny Nip Named in ALB Offshore Client Choice 2026

  We are pleased to announce that Partner and Head of PRC Group, Jenny Nip, has been selected as one of the 10 standout offshore lawyers in Asia in ALB Offshore Client Choice 2026. The list recognises top practitioners who have established the strongest client connections and won the highest recognition across Asia.

• Campbells advised Manycore Tech Inc. on its listing on the Main Board of HKEX

  Campbells is pleased to have acted as Cayman Islands legal counsel to Manycore Tech Inc. (“Manycore”) in connection with its approximately HK$1.2 billion initial public offering and listing of its 160,619,000 shares (subject to the Over-allotment Option) on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX).

• Campbells advises Ridge Outdoor International Limited on its listing on the Main Board of HKEX

  Campbells acted as Cayman Islands legal counsel to Ridge Outdoor International Limited in connection with its close to HK$350 million initial public offering and listing of its 28,205,000 shares on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX).

• Campbells advises Distinct Healthcare Holdings Limited on its listing on the Main Board of HKEX

  Campbells is pleased to have acted as Cayman Islands legal counsel to Distinct Healthcare Holdings Limited (卓正医疗控股有限公司, “Distinct Healthcare”) in connection with its close to HK$290 million initial public offering and listing of its 4,750,000 shares (subject to the over-allotment exercise) on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX)

• Campbells advised Chuangxin Industries Holdings Limited on its listing on the Main Board of the Hong Kong Stock Exchange

  Campbells has acted as the Cayman Islands and British Virgin Islands legal counsel of Chuangxin Industries Holdings Limited in connection with its approximately HK$5.5 billion initial public offering and listing of its 2.0 billion shares (subject to the over-allotment exercise) on the Main Board of the Hong Kong Stock Exchange. The Hong Kong Public Offering was oversubscribed by around 450 times, and it has attracted reputable investors including Swiss commodity giant Glencore PLC, Chinese investment manager Hillhouse Investment Management and US asset manager Millennium Management LLC.

• Campbells advised Youlife International Holdings Inc. and Youlife Group Inc. on the de-SPAC business combination with Distoken Acquisition Corporation, a NASDAQ listed special purpose acquisition

  Campbells acted as Cayman Islands legal counsel to Youlife International Holdings Inc. and Youlife Group Inc. on the de-SPAC business combination with Distoken Acquisition Corporation, a Nasdaq-listed special purpose acquisition company.

• Campbells advised MetaLight Inc. on its approximately HK$242.35 million listing on the Main Board of the Hong Kong Stock Exchange.

  Campbells acted as Cayman Islands legal counsel for MetaLight Inc. in connection with its approximately HK$242.35 million listing on the Main Board of the Hong Kong Stock Exchange. Despite the market situation, the Hong Kong Public Offering was very well received by the public and was oversubscribed by 274.44 times.

• Campbells acted as the Cayman Islands legal counsel of Bloks Group Limited on its initial public offering and listing on Hong Kong Stock Exchange

  Campbells acted as the Cayman Islands legal counsel of Bloks Group Limited in connection with its HK$1.6 billion initial public offering and listing on the Main Board of the Hong Kong Stock Exchange.

• Campbells advises Zhuhai Huafa Group as BVI legal counsel on its first issuance of the Digitally Native Bonds

  Campbells advised Huafa 2024 I Company Limited, a wholly-owned BVI subsidiary of Zhuhai Huafa Group Co., Ltd., as BVI legal counsel on its first issuance of Digitally Native Bonds.

• Campbells advised Mobvoi Inc. on its initial public offering on the Main Board of the Hong Kong Stock Exchange

  Campbells advised Mobvoi Inc., the first AI-generated content (AIGC) company listed on the Hong Kong Stock Exchange, in its HK$321.36 million initial public offering on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised Aptorum Group Limited (NASDAQ: APM) on its reverse merger with a privately-held Hong Kong AI business

  Campbells acted as Cayman Islands and British Virgin Islands counsel to Aptorum Group Limited (“Aptorum”) on the proposed US$250 million reverse merger with YOOV Group Holding Ltd (“YOOV”); and the simultaneous spin-off of APM’s existing business.

• Campbells is one of the top three offshore firms for HKIPOs in terms of fundraising value in the first five months of 2023

  Campbells is pleased to announce that, according to the information disclosed in the latest new listing report issued by the Hong Kong Stock Exchange, the firm is among the top three offshore firms in terms of value of funds raised in the first five months of 2023 from the initial public offerings on the Hong Kong Stock Exchange.

• Campbells advised Runhua Living Service Group Holdings Limited on its Hong Kong Stock Exchange listing

  Our Hong Kong office has acted as the Cayman and BVI legal counsel to Runhua Living Service Group Holdings Limited in connection with its approximately HK$127.5 million initial public offering and listing.

• Campbells advised Beauty Farm Medical and Health Industry Inc. on its HK Stock Exchange listing

  Campbells advised Beauty Farm Medical and Health Industry Inc. on its approximately HK$783 million initial public offering on the Hong Kong Stock Exchange.

• Campbells advised Sipai Health Technology Co. Ltd. on its Hong Kong Stock Exchange listing

  Campbells is delighted to have advised Sipai Health Technology Co., Ltd., a company dedicated to connect and deliver clear values to patients, doctors, medical institutions, pharmaceutical companies and payers across China’s healthcare system through its robust technology platform.

• Campbells advised Rainmed Medical Limited on its Hong Kong Stock Exchange listing

  Our Hong Kong office acted as Cayman Islands legal counsel to Rainmed Medical Limited in connection with its initial public offering and listing of its 23,348,000 shares (before exercise of over-allotment option) on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised Yonghe Medical Group Co., Ltd. on its HK$1.49 billion (approximately US$192 million) raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands and British Virgin Islands legal counsel to Yonghe Medical Group Co., Ltd. (“Yonghe Medical”) in connection with its HK$1.49 billion (approximately US$192 million) initial public offering and listing of its 94,424,000 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised Zhuahai Huafa Group Co., Ltd. on its issuance and listing on the Hong Kong Stock Exchange

  Campbells acted as BVI counsel to Huafa 2021 I Company Limited on its issuance and listing on the Hong Kong Stock Exchange of up to US$250,000,000 4.25% Senior Guaranteed Perpetual Capital Securities and up to US$200,000,000 2.95% Guaranteed Senior Bonds due 2025.

• Campbells advised Kangqiao Service Group Limited 康橋悅生活集團有限公司on its approximately HK$679 million raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands legal counsel to Kangqiao Service Group Limited 康橋悅生活集團有限公司 (“Kangqiao”) in connection with its approximately HK$679 million initial public offering and listing of its 175,000,000 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised UNQ Holdings Limited 優趣匯控股有限公司on its approximately HK$364 million raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands legal counsel to UNQ Holdings Limited 優趣匯控股有限公司 (“UNQ”) in connection with its approximately HK$364 million initial public offering and listing of its 30,690,600 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised Keymed Biosciences Inc. 康諾亞生物醫藥科技有限公司 on its approximately HK$3.1 billion raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands legal counsel to Keymed Biosciences Inc. 康諾亞生物醫藥科技有限公司 (“Keymed Biosciences”) in connection with its approximately HK$3.1 billion initial public offering and listing of its 58,264,500 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange.

• Jenny Nip Named in ALB’s Prestigious Offshore Client Choice List 2021

  We are pleased to announce that Jenny Nip, Head of our PRC Group, was recently selected by clients as one of Asia’s top ten standout offshore lawyers in the prestigious Asian Legal Business Offshore Client Choice List 2021.

• Campbells advised XD Inc. on its issuance of US$280 million 1.25% Convertible Bonds due 2026 listed on the Stock Exchange of Hong Kong Limited

  Campbells acted as the Cayman Islands and British Virgin Islands legal counsel for XD Inc. (“XD”) in connection with its issuance of US$280 million 1.25% Convertible Bonds due 2026 listed on the Stock Exchange of Hong Kong Limited.

• Campbells advised Hywin Holdings Ltd. on its US$30 million raise on the Nasdaq Capital Market

  Campbells acted as the Cayman Islands and British Virgin Islands legal counsel for Hywin Holdings Ltd. (“Hywin”) in connection with its US$30 million (and up to US$34.5 million upon exercise of the over-allotment option) raise on the Nasdaq Capital Market.

• Campbells advised Mediwelcome Healthcare Management & Technology Inc. (麥迪衛康健康醫療管理科技股份有限公司) on its HK$150 million (US$19.3 million) (and up to HK157.5 million (US$20.2 million) upon exercise of the over-allotment option) raise on the Hong Kong Stock Exchange

  Campbells acted as the Cayman Islands and British Virgin Islands legal counsel for Mediwelcome Healthcare Management & Technology Inc. (麥迪衛康健康醫療管理科技股份有限公司) (“Mediwelcome”) in connection with its HK$150 million (US$19.3 million) (and up to HK157.5 million (US$20.2 million) upon exercise of the over-allotment option) raise on the Hong Kong Stock Exchange.

• Campbells advised Joy Spreader Interactive Technology Ltd. (乐享互动有限公司) on its HK$1.57 billion (US$201 million) raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands and British Virgin Islands legal counsel to Joy Spreader Interactive Technology Ltd. (乐享互动有限公司) (“Joy Spreader”) in connection with its HK$1.57 billion (US$201 million) (and up to HK$1.80 billion (US$231 million) upon exercise of the over-allotment option) raise on the Hong Kong Stock Exchange. This IPO, oversubscribed more than 1600 times, was the third most sought-after in Hong Kong this year by retail investors.

• Campbells advised Honliv Healthcare Management Group Company Limited (宏力醫療管理集團有限公司) on its HK$315 million (US$40.5 million) (and up to HK$362 million (US$46.5 million) upon exercise of the over-allotment option) raise on the Hong Kong Stock Exchange

  Campbells acted as Cayman Islands and British Virgin Islands legal counsel for Honliv Healthcare Management Group Company Limited (宏力醫療管理集團有限公司)(“Honliv Healthcare”) in connection with its HK$315 million (US$40.5 million) (and up to HK$362 million (US$46.5 million) upon exercise of the over-allotment option) initial public offering on the Main Board of the Hong Kong Stock Exchange.

• Campbells advised Peijia Medical Limited on the second largest IPO on the Hong Kong Stock Exchange this year, raising HK$2.34 billion (US$301 million) (and up to $2.69 billion (US$346 million) upon exercise of the over-allotment option)

  Campbells acted as Cayman Islands and British Virgin Islands legal counsel for Peijia Medical Limited (“Peijia Medical”) on the second largest IPO on the Hong Kong Stock Exchange this year, raising HK$2.34 billion (US$301 million) (and up to $2.69 billion (US$346 million) upon exercise of the over-allotment option).

• Campbells advised Akeso, Inc. on its HK$2.58 billion (US$333 million) (and up to HK$2.97 billion (US$383 million) upon exercise of the over-allotment option) initial public offering on the main board of the Hong Kong Stock Exchange, in the biggest Hong Kong IPO this year

  Campbells acted as Cayman Islands and British Virgin Islands legal counsel to Akeso, Inc. in connection with its approximately HK$2.58 billion (US$333 million) (and up to HK$2.97 billion (US$383 million) upon exercise of the over-allotment option) initial public offering and listing of its 763,133,176 shares (and up to 787,057,176 shares upon exercise of the over-allotment option) on the Main Board of the Hong Kong Stock Exchange. This is the biggest Hong Kong IPO this year.

• Campbells advised Zhuahai Huafa Group Co., Ltd. on its bond issuance and listing on the Chongwa (Macao) Financial Asset Exchange (the “MOX”)

  Campbells acted as the British Virgin Islands legal counsel to Zhuahai Huafa Group Co., Ltd. on its issuance of up to U.S.$200,000,000 3.70% Guaranteed Bonds due 2020 which was listed with MOX in the Macau Special Administrative Region of the People’s Republic of China (“Macau”).

• Campbells advised Wenye Group Holdings Limited文業集團控股有限公司on its HK$157.4 million raise on the Hong Kong Stock Exchange

  Campbells acted as the Cayman Islands and British Virgin Islands legal counsel to Wenye Group Holdings Limited文業集團控股有限公司 (“Wenye Group”) in connection with its HK$157.4 million initial public offering and listing of its 148,500,000 shares (assuming the over-allotment option is not exercised) on the Main Board of the Hong Kong Stock Exchange.